Article

Cost-effectiveness of respiratory syncytial virus vaccination for older adults: a modelling analysis

2026-07-13

Abstract excerpt

<h4>Background</h4> Evidence of the effectiveness and cost-effectiveness of new vaccines that reduce the burden of respiratory syncytial virus (RSV) in older populations is emerging. The reported cost-effectiveness of these vaccination strategies varies substantially across different settings. This study assessed the cost-effectiveness of older adult-targeted RSV vaccination strategies in the Australian context a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: df1e1297-4def-5db0-bd6f-2e6878c1e51d
DOI: 10.64898/2026.07.08.26357577

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cost-effectiveness of respiratory syncytial virus vaccination for older adults: a modelling analysisDOI 10.64898/2026.07.08.26357577Read

Cost-effectiveness of the next generation of RSV intervention strategiesSemantic proximity Read

Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South AfricaSemantic proximity Read

The burden of RSV-associated illness in children aged <5 years, South Africa, 2011 to 2016Semantic proximity Read

Burden of Disease of Respiratory Syncytial Virus in Older Adults and Adults Considered at High Risk of Severe InfectionSemantic proximity Read

Cost-utility analysis of COVID-19 vaccination strategies for endemic SARS-CoV-2 circulation in CanadaSemantic proximity Read

Optimising age coverage of seasonal influenza vaccination in England: A mathematical and health economic evaluationSemantic proximity Read

Estimation of GP visits, hospitalizations and deaths attributable to RSV and influenza and costs associated with hospitalizations in older adults in France, 2010-2020Semantic proximity Read

Respiratory Syncytial Virus disease morbidity in Australian infants aged 0 to 6 months: A systematic review and evaluationSemantic proximity Read

Cost-effectiveness of routine COVID-19 adult vaccination programmes in EnglandSemantic proximity Read

Cost-effectiveness and cost-utility of COVID-19 vaccination in a South African privately insured population: a real-world claims-based analysisSemantic proximity Read

Economic Burden of RSV-Associated Hospitalizations in Switzerland: A Nationwide Analysis (2017–2023)Semantic proximity Read

Potential Cost-Effectiveness of RSV Vaccination of Infants and Pregnant Women in Turkey: An Illustration Based on Bursa DataSemantic proximity Read